Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: TGA Says Provisional Approval Of Celltrion Healthcare Australia Pty Ltd COVID-19 Treatment, Regdanvimab

Dec 6 (Reuters) - 
    * AUSTRALIA'S TGA SAYS PROVISIONAL APPROVAL OF CELLTRION
HEALTHCARE AUSTRALIA PTY LTD COVID-19 TREATMENT, REGDANVIMAB
(REGKIRONA)
    * TGA -REGKIRONA PROVISIONALLY APPROVED FOR INTRAVENOUS
TREATMENT
OF MILD-TO-MODERATE COVID-19 IN ADULT PATIENTS CONFIRMED TO BE
INFECTED WITH COVID-19
    * TGA -REGDANVIMAB (REGKIRONA) IS NOT INTENDED TO BE USED AS
A
SUBSTITUTE FOR VACCINATION AGAINST COVID-19


 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news